| NCCN Guidelines® insights: multiple myeloma, version 3.2022: featured updates to the NCCN guidelines NS Callander, M Baljevic, K Adekola, LD Anderson, E Campagnaro, ... Journal of the National Comprehensive Cancer Network 20 (1), 8-19, 2022 | 108 | 2022 |
| Factors associated with genital human papillomavirus infection among adult females in the United States, NHANES 2007–2010 R Shi, S Devarakonda, L Liu, H Taylor, G Mills BMC research notes 7, 1-8, 2014 | 58 | 2014 |
| Role of stem cell transplantation in multiple myeloma S Devarakonda, Y Efebera, N Sharma Cancers 13 (4), 863, 2021 | 32 | 2021 |
| The influence of anemia after percutaneous coronary intervention on clinical outcomes S Sattur, KJ Harjai, A Narula, S Devarakonda, P Orshaw, K Yaeger Clinical Cardiology: An International Indexed and Peer‐Reviewed Journal for …, 2009 | 32 | 2009 |
| Predictors of survival in acute myeloid leukemia by treatment modality S Master, R Mansour, SS Devarakonda, Z Shi, G Mills, R Shi Anticancer research 36 (4), 1719-1727, 2016 | 26 | 2016 |
| Potential of NK cells in multiple Myeloma therapy AM Khan, S Devarakonda, N Bumma, M Chaudhry, DM Benson Jr Expert review of hematology 12 (6), 425-435, 2019 | 18 | 2019 |
| AL amyloidosis: the effect of fluorescent in situ hybridization abnormalities on organ involvement and survival M Ozga, Q Zhao, D Benson Jr, P Elder, N Williams, N Bumma, A Rosko, ... Cancer Medicine 10 (3), 965-973, 2021 | 15 | 2021 |
| Occurrence, predictors, and outcomes of post‐percutaneous coronary intervention thrombocytopenia in an unselected population C Shenoy, P Orshaw, S Devarakonda, KJ Harjai Journal of interventional cardiology 22 (2), 156-162, 2009 | 15 | 2009 |
| Systemic light chain amyloidosis, version 2.2023, NCCN clinical practice guidelines in oncology SK Kumar, NS Callander, K Adekola, LD Anderson, M Baljevic, ... Journal of the National Comprehensive Cancer Network 21 (1), 67-81, 2023 | 11 | 2023 |
| Improvement in post-autologous stem cell transplant survival of multiple myeloma patients: a long-term institutional experience J Nunnelee, F Cottini, Q Zhao, MS Faisal, P Elder, A Rosko, N Bumma, ... Cancers 14 (9), 2277, 2022 | 11 | 2022 |
| Real world experience of daratumumab: evaluating lymphopenia and adverse events in multiple myeloma patients F Cottini, Y Huang, N Williams, N Bumma, AM Khan, M Chaudhry, ... Frontiers in Oncology 10, 575168, 2021 | 10 | 2021 |
| Effect of early post-transplantation tacrolimus concentration on the risk of acute graft-versus-host disease in allogenic stem cell transplantation N Sharma, Q Zhao, B Ni, P Elder, M Puto, DM Benson, A Rosko, ... Cancers 13 (4), 613, 2021 | 10 | 2021 |
| Multiple myeloma, version 3.2022: featured updates to the NCCN guidelines NS Callander, M Baljevic, K Adekola, LD Anderson, E Campagnaro, ... JNCCN Journal of the National Comprehensive Cancer Network 20 (1), 8-19, 2022 | 8 | 2022 |
| AL amyloidosis: the effect of maintenance therapy on autologous stem cell transplantation outcomes M Ozga, Q Zhao, D Benson, P Elder, N Williams, N Bumma, A Rosko, ... Journal of Clinical Medicine 9 (11), 3778, 2020 | 8 | 2020 |
| Improvement in survival of multiple myeloma patients: a long-term institutional experience J Nunnelee, Q Zhao, DM Benson Jr, AE Rosko, M Chaudhry, N Bumma, ... Blood 134, 4573, 2019 | 8 | 2019 |
| The Shreveport myeloma experience: survival, risk factors and other malignancies in the age of stem cell transplantation R Munker, R Shi, B Nair, S Devarakonda, JD Cotelingam, J McLarty, ... Acta Haematologica 135 (3), 146-155, 2016 | 8 | 2016 |
| Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020 S Devarakonda, F Cottini, N Bumma, A Khan, N Sharma, M Chaudhry, ... Journal of Clinical Medicine 9 (11), 3626, 2020 | 7 | 2020 |
| Heavy lifting: Nomenclature and novel therapy for gamma heavy chain disease and other heavy chain disorders S Singer, Y Efebera, N Bumma, A Khan, S Devarakonda, M Chaudhry, ... Clinical Lymphoma Myeloma and Leukemia 20 (8), 493-498, 2020 | 7 | 2020 |
| The effect of cytogenetic abnormalities on organ involvement and survival in patients with AL amyloidosis M Ozga, Q Zhao, DM Benson Jr, P Elder, N Williams, N Bumma, ... Blood 134, 1833, 2019 | 6 | 2019 |
| Risk factors and prevalence of genital HPV infection among adult females in US between 2003-2010: Data from NHANES study SS Devarakonda, A Neppalli, L Liu, E Friday, R Shi Cancer Research 74 (19_Supplement), 278-278, 2014 | 6 | 2014 |
naresh bummaOSUVerified email at osumc.edu
